McGeorge Anne has filed 7 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 67901 shares of Oncology Institute, Inc. ($TOI) on November 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | McGeorge Anne | Director | A | Common Stock | 67901 | $0.00 | 251,247.0000 | 99,303,511 | 37.03% | 0.07% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | McGeorge Anne | Director | A | Common Stock | 40123 | $0.00 | 291,370.0000 | 99,303,511 | 15.97% | 0.04% |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | McGeorge Anne | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 32,125,179 | 9999.99% | 0.04% |
| Nov. 22, 2024 | Oncology Institute, Inc. | $TOI | McGeorge Anne | Director | A | Common stock | 56000 | $0.00 | 183,346.0000 | 77,292,849 | 43.97% | 0.07% |
| May 23, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | McGeorge Anne | Not found | A | Stock Option (Right to Buy) | 11000 | $0.00 | 11,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | McGeorge Anne | Director | A | Common stock | 56000 | $0.00 | 127,346.0000 | 73,265,621 | 78.49% | 0.08% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | McGeorge Anne | Director | A | Common stock | 26247 | $0.00 | 71,346.0000 | 73,265,621 | 58.20% | 0.04% |